Polar Capital Holdings’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-452,669
| Closed | -$9.29M | – | 282 |
|
|
2024
Q1 | $9.29M | Hold |
452,669
| – | – | 0.05% | 205 |
|
|
2023
Q4 | $9.71M | Sell |
452,669
-554,417
| -55% | -$11.9M | 0.06% | 200 |
|
|
2023
Q3 | $20.8M | Hold |
1,007,086
| – | – | 0.15% | 139 |
|
|
2023
Q2 | $29.7M | Buy |
1,007,086
+502,086
| +99% | +$14.8M | 0.15% | 119 |
|
|
2023
Q1 | $11.6M | Buy |
+505,000
| New | +$11.6M | 0.08% | 178 |
|
|
2022
Q1 | – | Sell |
-53,835
| Closed | -$2.4K | – | 467 |
|
|
2021
Q4 | $2.4K | Hold |
53,835
| – | – | 0.01% | 288 |
|
|
2021
Q3 | $2.72K | Buy |
53,835
+5,037
| +10% | +$254 | 0.01% | 293 |
|
|
2021
Q2 | $3.83K | Buy |
+48,798
| New | +$3.83K | 0.02% | 289 |
|